Citation Impact
Citing Papers
The Contribution of Social Factors to the Development of Schizophrenia: A Review of Recent Findings
2007
Schizophrenia risk from complex variation of complement component 4
2016 StandoutNature
Depression
2018 Standout
Reduced prefrontal activity predicts exaggerated striatal dopaminergic function in schizophrenia
2002
Animal models of obstetric complications in relation to schizophrenia
2004
RIM1α and Interacting Proteins Involved in Presynaptic Plasticity Mediate Prepulse Inhibition and Additional Behaviors Linked to Schizophrenia
2010 StandoutNobel
Profound Decreases in Dopamine Release in Striatum in Detoxified Alcoholics: Possible Orbitofrontal Involvement
2007
Neuroplasticity of Neocortical Circuits in Schizophrenia
2007
The neuropathology of schizophrenia
1999
Maternal exposure to bacterial endotoxin during pregnancy enhances amphetamine-induced locomotion and startle responses in adult rat offspring
2003
Dysfunction of the prefrontal cortex in addiction: neuroimaging findings and clinical implications
2011 Standout
C. elegans EGL-9 and Mammalian Homologs Define a Family of Dioxygenases that Regulate HIF by Prolyl Hydroxylation
2001 StandoutNobel
The Rab5 Effector Rabankyrin-5 Regulates and Coordinates Different Endocytic Mechanisms
2004
Dopamine D2 receptor availability and amphetamine-induced dopamine release in unipolar depression
2001
NFAT dysregulation by increased dosage of DSCR1 and DYRK1A on chromosome 21
2006 StandoutNature
Functional neuroimaging in schizophrenia: diagnosis and drug discovery
2008
Neuroreceptor imaging in psychiatric disorders
2002
Anatomical and physiological evidence for D1 and D2 dopamine receptor colocalization in neostriatal neurons
2000 StandoutNobel
Striatal Dopamine Synthesis in First-degree Relatives of Patients with Schizophrenia
2007
The Role of Extrastriatal Dopamine D2 Receptors in Schizophrenia
2006
Brain Activation Elicited by Affectively Positive Stimuli Is Associated With a Lower Risk of Relapse in Detoxified Alcoholic Subjects
2007
Decreased Dopamine D2 Receptor Binding in the Anterior Cingulate Cortex in Schizophrenia
2002
How antipsychotics become anti-‘psychotic’ – from dopamine to salience to psychosis
2004
Δ9-Tetrahydrocannabinol Induces Dopamine Release in the Human Striatum
2008
Schizophrenia
2009 Standout
Presynaptic dopaminergic function in the striatum of schizophrenic patients
1997
Presynaptic Dopaminergic Dysfunction in Schizophrenia
2004
Cocaine Dependence and D2 Receptor Availability in the Functional Subdivisions of the Striatum: Relationship with Cocaine-Seeking Behavior
2004
Does phenylethylamine act as an endogenous amphetamine in some patients?
1999
Hallmarks of aging: An expanding universe
2023 Standout
Neural systems of reinforcement for drug addiction: from actions to habits to compulsion
2005 Standout
Linking nucleus accumbens dopamine and blood oxygenation
2007
DNA transfection mediated by cationic liposomes containing lipopolylysine: characterization and mechanism of action
1994
Neurobiology of Dopamine in Schizophrenia
2007
Gradients of dopamine D1- and D2/3-binding sites in the basal ganglia of pig and monkey measured by PET
2004
Dopamine Depletion and In Vivo Binding of PET D1 Receptor Radioligands: Implications for Imaging Studies in Schizophrenia
2003
Affective Circuitry and Risk for Alcoholism in Late Adolescence: Differences in Frontostriatal Responses Between Vulnerable and Resilient Children of Alcoholic Parents
2008
Contributions of the Amygdala to Emotion Processing: From Animal Models to Human Behavior
2005 Standout
Dopamine gating of forebrain neural ensembles
2003
Glutamate and Schizophrenia: Phencyclidine, N‐Methyl‐d‐Aspartate Receptors, and Dopamine–Glutamate Interactions
2007
Prefrontal neurons and the genetics of schizophrenia
2001
Rab GTPases as coordinators of vesicle traffic
2009 Standout
A robust and high-throughput Cre reporting and characterization system for the whole mouse brain
2009 Standout
Neurobiology of schizophrenia
1997
Subtle Fluctuations in Psychotic Phenomena as Functional States of Abnormal Dopamine Reactivity in Individuals at Risk
2005
Elevated Striatal Dopamine Function Linked to Prodromal Signs of Schizophrenia
2009
Evidence for Onset of Antipsychotic Effects Within the First 24 Hours of Treatment
2005
Modulation of amphetamine-induced striatal dopamine release by ketamine in humans: implications for schizophrenia
2000 StandoutNobel
Network interactions in schizophrenia — therapeutic implications
2000 StandoutNobel
Transient and Selective Overexpression of Dopamine D2 Receptors in the Striatum Causes Persistent Abnormalities in Prefrontal Cortex Functioning
2006 Nobel
Effects of NMDA antagonism on striatal dopamine release in healthy subjects: Application of a novel PET approach
1998
Recent Advances in the Development of Novel Pharmacological Agents for the Treatment of Cognitive Impairments in Schizophrenia
2007
Network organization of the human autophagy system
2010 StandoutNature
From dopamine to salience to psychosis—linking biology, pharmacology and phenomenology of psychosis
2005
A network of dopaminergic gene variations implicated as risk factors for schizophrenia
2007
The therapeutic potential of the cerebellum in schizophrenia
2014
Increased dopamine synthesis rate in medial prefrontal cortex and striatum in schizophrenia indicated by L-(β-11C) DOPA and PET
1999
Metazoan MicroRNAs
2018 Standout
Insulin receptor internalization: molecular mechanisms and physiopathological implications
1994
Autism-Associated Neuroligin-3 Mutations Commonly Disrupt Tonic Endocannabinoid Signaling
2013 StandoutNobel
Effects of catecholamine depletion on D2 receptor binding, mood, and attentiveness in humans: a replication study
2002
Psychosis as a State of Aberrant Salience: A Framework Linking Biology, Phenomenology, and Pharmacology in Schizophrenia
2002 Standout
Differential Function of the Prolyl Hydroxylases PHD1, PHD2, and PHD3 in the Regulation of Hypoxia-inducible Factor
2004 StandoutNobel
Aberrant Hippocampal Activity Underlies the Dopamine Dysregulation in an Animal Model of Schizophrenia
2007
Subchronic Haloperidol Downregulates Dopamine Synthesis Capacity in the Brain of Schizophrenic Patients In Vivo
2002
Mapping, Characterization, and Expression Analysis of the SM-20 Human Homologue, C1orf12, and Identification of a Novel Related Gene, SCAND2
2000
A distributional code for value in dopamine-based reinforcement learning
2020 StandoutNatureNobel
The Dopamine Hypothesis of Schizophrenia: Version III--The Final Common Pathway
2009 Standout
Stability of [123I]IBZM SPECT measurement of amphetamine-induced striatal dopamine release in humans
1999
Half a century of antipsychotics and still a central role for dopamine D2 receptors
2003
Neocortical excitation/inhibition balance in information processing and social dysfunction
2011 StandoutNature
Circuit-based framework for understanding neurotransmitter and risk gene interactions in schizophrenia
2008
A pathophysiological framework of hippocampal dysfunction in ageing and disease
2011
Cannabis, the mind and society: the hash realities
2007
Early and Late Neurodevelopmental Influences in the Prodrome to Schizophrenia: Contributions of Genes, Environment, and Their Interactions
2003
Rethinking schizophrenia
2010 StandoutNature
The Dopamine D2 Receptors in High-Affinity State and D3 Receptors in Schizophrenia: A Clinical [11C]-(+)-PHNO PET Study
2008
Differential synaptic changes in the striatum of subjects with undifferentiated versus paranoid schizophrenia
2008
The hippocampal–striatal axis in learning, prediction and goal-directed behavior
2011
Dopamine D2 receptor binding in drug-naïve patients with schizophrenia examined with raclopride-C11 and positron emission tomography
2006
Dopamine receptors in the brains of schizophrenia patients: a meta-analysis of the findings
2001
Directed evolution of a magnetic resonance imaging contrast agent for noninvasive imaging of dopamine
2010 StandoutNobel
Dopamine D2 receptor occupancy by risperidone: Implications for the timing and magnitude of clinical response
2006
Supra-regional Brain Systems and the Neuropathology of Schizophrenia
1999
Striatal amphetamine-induced dopamine release in patients with schizotypal personality disorder studied with single photon emission computed tomography and [123I]iodobenzamide
2004
Functional organization of the hippocampal longitudinal axis
2014 StandoutNobel
In Vivo DA D1 Receptor Selectivity of NNC 112 and SCH 23390
2007
Targeting the dopamine D1 receptor in schizophrenia: insights for cognitive dysfunction
2004
Neurotransmitter interactions in schizophrenia—therapeutic implications
1999 StandoutNobel
Subchronic Phencyclidine Administration Increases Mesolimbic Dopaminergic System Responsivity and Augments Stress- and Psychostimulant-Induced Hyperlocomotion
1998
Major Depressive Disorder
2008 Standout
Modeling Sensitization to Stimulants in Humans
2006
Macrophage complement receptors and pathogen clearance
2007
Effects of acute metabolic stress on the dopaminergic and pituitary–adrenal axis activity in patients with schizophrenia, their unaffected siblings and controls
2007
Dendritic spine pathology in schizophrenia
2012
Birth insult interacts with stress at adulthood to alter dopaminergic function in animal models: possible implications for schizophrenia and other disorders
2003
Sex Differences in Striatal Dopamine Release in Young Adults After Oral Alcohol Challenge: A Positron Emission Tomography Imaging Study With [11C]Raclopride
2010
Psychosis pathways converge via D2High dopamine receptors
2006
β-Arrestins Regulate Mitogenic Signaling and Clathrin-mediated Endocytosis of the Insulin-like Growth Factor I Receptor
1998 StandoutNobel
6-18F-DOPA PET study in patients with schizophrenia
2000
Dysfunction of ventral striatal reward prediction in schizophrenia
2005
Animal models of neuropsychiatric disorders
2010
The Endophenotype Concept in Psychiatry: Etymology and Strategic Intentions
2003 Standout
The Neuropsychopharmacology of Phencyclidine From NMDA Receptor Hypofunction to the Dopamine Hypothesis of Schizophrenia
1999
Neurotransmitter aberrations in schizophrenia: New perspectives and therapeutic implications
1997 StandoutNobel
Do patients with schizophrenia exhibit aberrant salience?
2008
Dopaminergic Supersensitivity in G Protein-Coupled Receptor Kinase 6-Deficient Mice
2003 StandoutNobel
NMDA antagonist effects on striatal dopamine release: Positron emission tomography studies in humans
2001
Thalamic miR-338-3p mediates auditory thalamocortical disruption and its late onset in models of 22q11.2 microdeletion
2016
Probing Brain Reward System Function in Major Depressive Disorder
2002
Pharmacological modulation of functional connectivity: the correlation structure underlying the phMRI response to d-amphetamine modified by selective dopamine D3 receptor antagonist SB277011A
2007
The role of endogenous sensitization in the pathophysiology of schizophrenia: Implications from recent brain imaging studies
2000
Stress-Induced Dopamine Release in Humans at Risk of Psychosis: a [11C]Raclopride PET Study
2007
D2/D3 dopamine receptor binding with [F-18]fallypride in thalamus and cortex of patients with schizophrenia
2006
Cognitive Enhancers as Adjuncts to Psychotherapy
2004
To Model a Psychiatric Disorder in Animals Schizophrenia As a Reality Test
2000
Neurocircuitry of Addiction
2009 Standout
The principal features and mechanisms of dopamine modulation in the prefrontal cortex
2004
Dopaminergic activities in the human striatum: rostrocaudal gradients of uptake sites and of D1 and D2 but not of D3 receptor binding or dopamine
1999
The Presynaptic Active Zone Protein RIM1α Is Critical for Normal Learning and Memory
2004 StandoutNobel
Striatal dopamine D1 and D2 receptor balance in twins at increased genetic risk for schizophrenia
2005
Parkinson's Disease
2003 Standout
Psychosocial Stress and Psychosis. A Review of the Neurobiological Mechanisms and the Evidence for Gene-Stress Interaction
2008
Microglia Sculpt Postnatal Neural Circuits in an Activity and Complement-Dependent Manner
2012 Standout
Complex brain networks: graph theoretical analysis of structural and functional systems
2009 Standout
Direct binding and functional coupling of α-synuclein to the dopamine transporters accelerate dopamine-induced apoptosis
2001
Characterization of different isoforms of the HIF prolyl hydroxylase PHD1 generated by alternative initiation
2006 StandoutNobel
Fluorine in Pharmaceutical Industry: Fluorine-Containing Drugs Introduced to the Market in the Last Decade (2001–2011)
2013 Standout
High levels of dopamine D2 receptors in unaffected members of alcoholic families: possible protective factors.
2006
Imaging Synaptic Neurotransmission with in Vivo Binding Competition Techniques: A Critical Review
2000
Overlapping neuronal circuits in addiction and obesity: evidence of systems pathology
2008
Molecular imaging studies of the striatal dopaminergic system in psychosis and predictions for the prodromal phase of psychosis
2007
The Computational Anatomy of Psychosis
2013
Delta-9-tetrahydrocannabinol effects in schizophrenia: Implications for cognition, psychosis, and addiction
2005
Nonviral Vectors for Gene Delivery
2008 Standout
Next Generation of Fluorine-Containing Pharmaceuticals, Compounds Currently in Phase II–III Clinical Trials of Major Pharmaceutical Companies: New Structural Trends and Therapeutic Areas
2016 Standout
A glutamatergic deficiency model of schizophrenia
1999 StandoutNobel
Review: Glutamate and dopamine dysregulation in schizophrenia — a synthesis and selective review
2007
Executive Functions
2012 Standout
How antipsychotics work—From receptors to reality
2006
Pavlovian conditioning–induced hallucinations result from overweighting of perceptual priors
2017 StandoutScience
SIRT6, a Mammalian Deacylase with Multitasking Abilities
2019
Inositol hexakisphosphate suppresses excitatory neurotransmission via synaptotagmin-1 C2B domain in the hippocampal neuron
2012 StandoutNobel
The Cognitive Neuroscience of Schizophrenia
2005
Schizophrenia is associated with elevated amphetamine-induced synaptic dopamine concentrations: Evidence from a novel positron emission tomography method
1997
Functional and Anatomical Aspects of Prefrontal Pathology in Schizophrenia
1997
Imaging neurochemical endophenotypes: promises and pitfalls
2001
Current and Novel Approaches to the Drug Treatment of Schizophrenia
2001
Nanoparticle Size and Surface Chemistry Determine Serum Protein Adsorption and Macrophage Uptake
2011 Standout
Emerging drugs for schizophrenia
2008
DESENSITIZATION OF G PROTEIN–COUPLED RECEPTORS AND NEURONAL FUNCTIONS
2004 StandoutNobel
Effect of COMT Val 108/158 Met genotype on frontal lobe function and risk for schizophrenia
2001 Standout
Applications of Clinical Dopamine Imaging
2006
Cellular uptake of nanoparticles: journey inside the cell
2017 Standout
Macropinocytosis: an endocytic pathway for internalising large gulps
2011
Dopamine as the wind of the psychotic fire: new evidence from brain imaging studies
1999
Conditional calcineurin knockout mice exhibit multiple abnormal behaviors related to schizophrenia
2003 Nobel
Works of Roberto Gil being referenced
Increased Striatal Dopamine Transmission in Schizophrenia: Confirmation in a Second Cohort
1998
Altered Prefrontal Dopaminergic Function in Chronic Recreational Ketamine Users
2005
Alcohol Dependence Is Associated with Blunted Dopamine Transmission in the Ventral Striatum
2005
Increased Synaptic Dopamine Function in Associative Regions of the Striatum in Schizophrenia
2010
SIRT6 exhibits nucleosome-dependent deacetylase activity
2013
Dopamine and serotonin transporters in patients with schizophrenia: an imaging study with [123I]β-CIT
2000
Increased dopamine transmission in schizophrenia: relationship to illness phases
1999
Occupancy of dopamine D 2 receptors by the atypical antipsychotic drugs risperidone and olanzapine: theoretical implications
2003
SPECT imaging of synaptic dopamine release in drug free schizophrenic patients: An experimental validation of the dopamine hypothesis of schizophrenia
1996
Internalization pathway of C3b receptors in human neutrophils and its transmodulation by chemoattractant receptors stimulation.
1991
Single photon emission computerized tomography imaging of amphetamine-induced dopamine release in drug-free schizophrenic subjects.
1996
Increased prefrontal cortical D1receptors in drug naïve patients with schizophrenia: a PET study with [11C]NNC112
2011
Prefrontal Dopamine D1Receptors and Working Memory in Schizophrenia
2002
IV glycine and oral d-cycloserine effects on plasma and CSF amino acids in healthy humans
2000
Increased baseline occupancy of D 2 receptors by dopamine in schizophrenia
2000 Standout